Prostate-Specific Membrane Antigen PET Before Aggressive Local Therapy to the Sternum

In the absence of major competing medical comorbidities, durable local control will be a significant issue during the projected lifetime of this man (1). In men who present with such high-volume and high-grade (group 5) prostate disease concurrently with lower urinary tract symptoms, insufficient control long term is often observed with medical management alone.

http://ift.tt/2qAvRZo